[Clinical study of bufexamac in the treatment of post-partum hemorrhoids following episiotomy].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D004841:Episiotomy / Q000009:adverse effects*; D005260:Female; D006484:Hemorrhoids / Q000188:drug therapy*; D006801:Humans; D006877:Hydroxamic Acids / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010648:Phenylacetates / Q000627:therapeutic use; D011247:Pregnancy; D011644:Puerperal Disorders / Q000188:drug therapy; D014945:Wound Healing
D000893:Anti-Inflammatory Agents; D006877:Hydroxamic Acids; D010648:Phenylacetates
Etude clinioue du bufexamac dans le traitement des hemorroides du post-partum apres episiotomie